PT - JOURNAL ARTICLE AU - Riglin, Lucy AU - Agha, Sharifah Shameem AU - Eyre, Olga AU - Jones, Rhys Bevan AU - Wootton, Robyn E AU - Thapar, Ajay K AU - Collishaw, Stephan AU - Stergiakouli, Evie AU - Langley, Kate AU - Thapar, Anita TI - Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood AID - 10.1101/2021.02.02.20248239 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.02.20248239 4099 - http://medrxiv.org/content/early/2021/02/03/2021.02.02.20248239.short 4100 - http://medrxiv.org/content/early/2021/02/03/2021.02.02.20248239.full AB - Attention Deficit Hyperactivity Disorder (ADHD) symptoms typically onset early in development and persist into adulthood for many. Robust investigation of symptom continuity and discontinuity requires repeated assessments using the same measure, but research is lacking into whether measures used to assess ADHD symptoms in childhood are also valid in adulthood. The Strengths and Difficulties Questionnaire (SDQ) has been widely used to measure ADHD symptoms in children, but little is known about its utility to measure ADHD in adulthood. We used Receiver Operating Characteristic (ROC) curve analyses to examine the validity of the SDQ hyperactivity/ADHD subscale to distinguish between cases and non-cases of DSM-5 ADHD classified using the Barkley Adult ADHD Rating Scale-IV (BAARS-IV) at age 25 years in a UK population cohort (N=4121). Analyses suggested that the SDQ ADHD subscale had high accuracy in distinguishing ADHD cases from non-cases in young adulthood (area under the curve=0.90, 95% CI=0.87-0.93) and indicated a lower cut-point for identifying those who may have an ADHD diagnosis in this age group compared to that currently recommended for younger ages.Our findings suggest that the SDQ is suitable for ADHD research across different developmental periods, which will aid the robust investigation of ADHD from childhood to young adulthood.HighlightsThe SDQ is widely used to measure ADHD symptoms in childrenWe investigated the validity of the SDQ to assess ADHD at age 25 yearsThe SDQ ADHD subscale had high accuracy in distinguishing DSM-5 ADHD cases from non-casesA lower cut-point is needed to identify ADHD diagnosis in young adulthood compared to younger agesThe SDQ is appropriate for ADHD research across different development periodsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe measures used in the paper were specifically funded by the Wellcome Trust (204895/Z/16/Z). REW and ES work in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1 and MC_UU_00011/3). RBJ is supported by the Welsh Government through Health and Care Research Wales (National Institute for Health Research Fellowship, NIHR-PDF-2018). REW is supported by a postdoctoral fellowship from the South-Eastern Regional Health Authority (2020024). This study was supported by the Wellcome Trust (204895/Z/16/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee (IRB00003312) and Local Research Ethics Committees which includes:Bristol and Weston Health Authority: E1808 Children of the Nineties: Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC). (28th November 1989)Southmead Health Authority: 49/89 Children of the Nineties – “ALSPAC”. (5th April 1990)Frenchay Health Authority: 90/8 Children of the Nineties. (28th June 1990)Further details of these can be found on our webpages at http://www.bristol.ac.uk/media-library/sites/alspac/documents/governance/Research%20Ethics%20Committee%20approval%20references.pdfAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool: http://www.bristol.ac.uk/alspac/researchers/our-data/.